Background and objectives: Phylloides tumors are categorized as benign, borderline and malignant on the basis of histological features which are subjected to significant inter-observer variability. Our aim was to study the role of immunohistochemical expression of CD10 in discriminating benign, borderline and malignant categories of phylloides tumor.
Introduction
, also known as CALLA (common acute lymphoblastic leukemia antigen), is a matrix metalloprotease which is responsible for stromal differentiation and tumor invasiveness. It has established diagnostic role in hematolymphoid malignancies such as acute lymphoblastic leukemia/lymphoma, follicular lymphoma, Burkitt's lymphoma and non-hematolymphoid malignancies such as endometrial stromal tumors, renal cell carcinoma and hepatocellular carcinoma [1] [2] [3] . It is also expressed in a variety of other nonhematopoietic malignancies as well as in normal myoepithelial cells in breast [4, 5] .
Phylloides tumors (PTs) are biphasic breast neoplasms of fibroepithelial origin, accounting for less than 1% of all the breast tumors [6] . These tumors are characterized by the overgrowth of stromal component with compression of breast ducts (epithelial component) and therefore impart a typical leaf life gross appearance [7, 8] . Like other breast tumors, PTs also possess the potential of recurrence or metastasis [9, 10] . These tumors are generally less aggressive and less frequently recur or metastasize as compared to the breast carcinomas.
In order to predict the possible behavior and outcome, these tumors are classified into benign, borderline and malignant categories [8] . Malignant PTs have the highest recurrence (36-65%) and metastatic frequency (35%) and benign PTs have the lowest recurrence (8-21%) and metastatic frequency (7%) [9, 10] . The categorization of PTs is based on certain morphologic features including tumor borders, stromal overgrowth, stromal atypia, mitotic figures and presence of heterologous components [8] . Owing to the heterogeneity of these morphologic features and inter-observer variability, classifying individual tumors accurately into these categories is not always simple [11] . Furthermore, none of these morphologic features individually predicts the behavior of the tumor. Few researchers have attempted to determine the role of immunohistochemistry (IHC) as a predictive tool. Immunohistochemical markers like p53, CD 31, CD34, CD 117, vimentin, actin , VEGF and EGFR have been evaluated for differential expression in the different categories of PT few have demonstrated a significant role in distinguishing between these categories [11] [12] [13] [14] [15] [16] [17] [18] [19] .
The differential expression of CD10 has also been evaluated PTs' categories, with the results showing an increased expression in malignant cases [20] [21] [22] [23] . As the studies conducted so far are still few and need to be validated with further studies on a larger number of cases. Information about the possible behavior and outcome of the tumor is one of the major concerns for oncologist, as it guides to the selection of appropriate treatment modalities. Surgery alone is the mainstay of treatment for benign PTs and malignant PTs may require further treatment such as radiotherapy and/ or chemotherapy [24] [25] [26] [27] .
The aim of our study was to evaluate the role of CD 10 immunohistochemical stain in categorizing phylloides tumors.
We included the excisional biopsy, wide local excision, mastectomy and modified radical mastectomy (MRM) specimens. Trucut biopsies, incisional biopsies and blocks received (from outside) for second opinion were not included. Moreover, specimen with poor fixation and processing artifacts were also excluded. Verbal informed consent was obtained from the patients via telephonic conversation on their contact numbers mentioned at the requisition slips. Pathology reports and slides of the cases were reviewed and data regarding the patient's age, and pathological features such as tumor size, tumor borders, resection margin status, stromal cellularity, stromal overgrowth, nuclear atypia, necrosis, heterologous element and mitotic counts was obtained. These cases were divided into three categories including benign, borderline, and malignant according to WHO criteria [8] .
Representative block of the tumor with maximum cellularity and internal control of myoepithelial cells was selected for prospective staining with CD10 immunohistochemical staining. 3-4 µm thick sections of paraffin embedded tissue were placed on poly-L-Lysine coated slides and kept overnight at 37 o C. For deparaffinization, the slides were dewaxed with xylene and then rehydrated with 80%,90% and 100% alcohol and distilled water. Antigen retrieval was done by incubating the slides for 20 minutes in microwave at 450 watts. Peroxidase activity was blocked by placing hydrogen peroxidase on slides. Commercially available monoclonal (ready to use) CD10 antibody (code 56C6, Dako) was placed on slide for 30 minutes followed by washing with Xylene, distilled water & further addition of secondary antibody. After washing DAB (chromogen) was added. Slides were counter stained with Haematoxlin and subsequently washed. Immunohistochemical staining was performed on the selected slides (as per kit manufacturer's instructions) by a technologist, utilizing Immunostaining was assessed by at least two pathologists who were unaware of the histological diagnosis. In case of discrepancy, the staining was reassessed by both pathologists and if the discrepancy remained, third pathologist assessed staining. The percentage of stromal cells staining positive was scored from 0% to 100%. Staining intensity was scored as 0, 1+, 2+ and 3+ (no staining, weak, moderate and strong staining, respectively). IHC was considered positive for CD10 if more than 20% stromal cells exhibit moderate (+2) to strong (+3) expression [22] .
Statistical analysis
Mean, median and ranges were calculated for age, tumor size and mitotic count, whereas percentages of different histological features and CD 10 positive cases in benign, borderline, malignant categories were calculated. Pearson Chi-Square test was applied to examine the correlation of CD10 expression and histological features with tumor categories.
Results
All of the 85 retrieved cases were females. Out of these, 62 (72.9%) were breast lumps (excisional biopsy and wide local excision specimens), followed by 10 (11.8%) simple mastectomy specimens, 12 (14.1%) were MRM specimens and 1 breast lump with axillary lymph nodes. Overall summary of clinicopathological features of phylloides tumor is given in Table 1 .
When categorized according to WHO criteria, 27 (31.8%) cases were benign, 25 (29.4%) were borderline and 33 (38.8%) were malignant. Comparison of various clinical features and histopathological characters among the three categories of phylloides tumors is given in Table 2 . Necrosis was present in 5 (15.2%) out of 33 malignant cases and 2 (6.1%) out of 33 malignant cases showed sarcomatous transformation. Skin ulceration was observed in 2/25 (8%) borderline and 3/33 (9.1%) malignant cases. Positive CD 10 staining (2+ or 3+) was observed in 5/27 (18.5%) benign cases, 16/25 (64%) borderline cases and 26/33 (78.8%) malignant cases (Figures 1-4) . Apart from stromal proliferation, epithelial proliferative lesions were also observed including intraductal papilloma (1 case), usual ductal hyperplasia (6 cases), atypical ductal hyperplasia (1 case) and ductal carcinoma in situ (2 cases) ( Table 3 ).
CD10 positive expression and increase in tumor size significantly correlated with increase in tumor category (p<0.0001). Among histological features, stromal atypia, stromal cellularity and mitotic count differed significantly in the tumor categories (p<0.0001). Patient's age, necrosis, sacromatous transformation and skin ulceration did not significantly correlated with tumor category ( Table 3 ). We also observed histological features such as increase in stromal atypia, stromal cellularity, tumor margin and mitotic activity to correlate significantly with increase in CD10 expression (p<0.0001) ( Table 4 ).
Discussion
CD10 immunohistochemical expression in myoepithelial cells of the breast duct is unique in the sense that the epithelial cells and Skin ulceration 00 02 (8%) 03 (9.1%) p = 0.286 *Based upon CD10 staining scores, the cases were termed CD10 positive and CD10 negative. Cases with score of 0 and 1+ were considered negative while cases with score of 2+ and 3+ were considered positive. other components of normal breast stroma such as fibroblasts, myofibroblasts, and smooth muscle do not stain for CD10 while myoepithelial cells also demonstrate positivity for cytokeratins, actin and S100. Therefore, expression of CD10 in myoepithelial cells serves as a good internal control [28, 29] .
In English literature, so far five studies have been conducted with an objective of evaluating CD10 expression in phylloides tumors' categories. In the most recent study of 71 phylloides tumor cases, Hussein et al. [30] , has reported significantly increasing CD10 expression when moving from benign to malignant categories. He also found age groups (<30, 30-50 and >50) and race to correlate significantly with tumor categories while Tumor size and recurrence rates were not significantly different among tumor categories. Al-Masri M et al. [23] , in his study of 43 cases, demonstrated significantly increasing CD10 expression with increasing malignancy in tumor categories. He also reported a significant difference in expression of CD10 in metastatic and non-metastatic cohorts. Tumor size, but not patient's age correlated with tumor grade. Tsai et al. [22] , also found CD10 along with ASMA to be discriminating between Phylloides tumor categories. Although the study was conducted only on 22 cases but the results were statistically significant. Tse et al. [20] , conducted the largest study of 181 cases to evaluate CD10 expression in Phylloides as well as including 33 fibroadenoma. He found an increasing immunoexpression trend with increasing malignancy trend. Age and tumor size also correlated significant with tumor grades in his study. In contrast, Zamenick et al. [21] , did not observed significant difference of CD10 staining in fibroadenoma and Phylloides tumor categories.
We observed an increase in percentage of CD 10 positive cases from benign to malignant cases. Since it is a metalloprotease, its increased expression reflects the metastatic potential of the tumors in general so like other authors [16] , we also think that this staining pattern is attributed to metalloprotease nature of the molecule which contributes to the malignant potential of tumor by allowing the tumor cells to invade surrounding stroma.
We also found the histological features such as stromal atypia, stromal cellularity and mitotic count to hold their significance in categorizing Phylloides tumor, as they differ significantly in tumor categories along with tumor size. Moreover, increase in stromal atypia, stromal cellularity, mitotic count and tumor margins correlated with increase in CD10 expression also. In our opinion, this correlation is attributed to the increase in proliferative nature of tumor cells which further explains the aggressive behavior of higher tumor grades.
Conclusion
On the basis of the significant results of this study conducted on a large cohort, we conclude that CD10 immunohitochemical staining is helpful in discriminating Phylloides tumors into histologic categories but CD10 expression should always be used as an adjunct tool along with histologic features. 
